Carolinas Wealth Consulting’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-524
| Closed | -$52.9K | – | 114 |
|
|
2025
Q1 | $52.9K | Sell |
524
-2
| -0.4% | -$202 | 0.01% | 344 |
|
|
2024
Q4 | $47K | Sell |
526
-109
| -17% | -$9.74K | 0.01% | 371 |
|
|
2024
Q3 | $53.2K | Sell |
635
-98
| -13% | -$8.21K | 0.01% | 352 |
|
|
2024
Q2 | $56.4K | Buy |
733
+44
| +6% | +$3.39K | 0.01% | 349 |
|
|
2024
Q1 | $47.2K | Sell |
689
-24
| -3% | -$1.64K | 0.01% | 385 |
|
|
2023
Q4 | $41.2K | Sell |
713
-2
| -0.3% | -$116 | 0.01% | 363 |
|
|
2023
Q3 | $36.6K | Buy |
715
+10
| +1% | +$512 | 0.01% | 349 |
|
|
2023
Q2 | $38.1K | Buy |
705
+674
| +2,174% | +$36.5K | 0.01% | 388 |
|
|
2023
Q1 | $1.55K | Hold |
31
| – | – | ﹤0.01% | 840 |
|
|
2022
Q4 | $1.43K | Sell |
31
-100
| -76% | -$4.63K | ﹤0.01% | 851 |
|
|
2022
Q3 | $5K | Hold |
131
| – | – | ﹤0.01% | 652 |
|
|
2022
Q2 | $5K | Hold |
131
| – | – | ﹤0.01% | 648 |
|
|
2022
Q1 | $6K | Hold |
131
| – | – | ﹤0.01% | 673 |
|
|
2021
Q4 | $6K | Hold |
131
| – | – | ﹤0.01% | 681 |
|
|
2021
Q3 | $6K | Hold |
131
| – | – | ﹤0.01% | 646 |
|
|
2021
Q2 | $6K | Hold |
131
| – | – | ﹤0.01% | 669 |
|
|
2021
Q1 | $5K | Hold |
131
| – | – | ﹤0.01% | 697 |
|
|
2020
Q4 | $5K | Sell |
131
-1,276
| -91% | -$48.7K | ﹤0.01% | 641 |
|
|
2020
Q3 | $54K | Buy |
1,407
+1,276
| +974% | +$49K | 0.02% | 268 |
|
|
2020
Q2 | $5K | Buy |
+131
| New | +$5K | ﹤0.01% | 390 |
|